Capricor Therapeutics, Inc.
(NASDAQ : CAPR)

( )
CAPR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -3.01%72.511.0%$1825.82m
AMGNAmgen, Inc. -2.43%197.811.3%$868.05m
REGNRegeneron Pharmaceuticals, Inc. 1.71%496.652.6%$847.12m
BIIBBiogen, Inc. -7.31%293.271.5%$701.26m
VRTXVertex Pharmaceuticals, Inc. -5.24%225.481.9%$548.05m
MRNAModerna, Inc. -0.94%29.670.0%$496.02m
ILMNIllumina, Inc. -6.10%256.463.5%$445.50m
ALXNAlexion Pharmaceuticals, Inc. 0.16%89.932.0%$283.26m
AAgilent Technologies, Inc. -3.67%68.991.6%$216.32m
EXASEXACT Sciences Corp. -3.66%55.8821.0%$182.49m
INCYIncyte Corp. 1.30%74.182.5%$177.83m
BMRNBioMarin Pharmaceutical, Inc. -1.08%83.594.3%$161.67m
SGENSeattle Genetics, Inc. -3.59%111.246.1%$150.70m
NVAXNovavax, Inc. 3.31%14.03114.7%$123.70m
ALNYAlnylam Pharmaceuticals, Inc. -3.96%104.548.7%$96.98m

Company Profile

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA.